Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-10-10
2010-02-23
McIntosh, III, Traviss C (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S043000, C514S049000, C536S026100, C536S028100, C536S028400, C536S028500, C536S028510
Reexamination Certificate
active
07666856
ABSTRACT:
4-Amino-1-((2R,3S,4S,5R)-5-azido-4-hydroxy-5-hydroxymethyl-3-methyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (22) and prodrugs thereof are hepatitis C (HCV) polymerase inhibitors. Also disclosed are compositions and methods for inhibiting HCV and treating HCV-mediated diseases, processes for making the compounds and synthetic intermediates employed in the process.
REFERENCES:
patent: 5034518 (1991-07-01), Montgomery et al.
patent: 5246924 (1993-09-01), Fox et al.
patent: 5587362 (1996-12-01), Chu et al.
patent: 6348587 (2002-02-01), Schinazi et al.
patent: 6784166 (2004-08-01), Devos et al.
patent: 6846810 (2005-01-01), Martin et al.
patent: 6864244 (2005-03-01), Connolly et al.
patent: 7456155 (2008-11-01), Sommadossi et al.
patent: 2004/0259934 (2004-12-01), Olsen et al.
patent: 2005/0038240 (2005-02-01), Connolly et al.
patent: 292023 (1988-11-01), None
patent: 352248 (1990-01-01), None
patent: 357571 (1990-07-01), None
patent: 547008 (1993-06-01), None
patent: WO 88/08001 (1988-10-01), None
patent: WO 00/69876 (2000-11-01), None
patent: WO 00/69877 (2000-11-01), None
patent: WO 01/32153 (2001-05-01), None
patent: WO 01/90121 (2001-11-01), None
patent: WO 01/92282 (2001-12-01), None
patent: WO 02/18404 (2002-03-01), None
patent: WO 02/005787 (2002-07-01), None
patent: WO 02/057425 (2002-07-01), None
patent: WO 02/100415 (2002-12-01), None
patent: WO 03/026589 (2003-04-01), None
patent: WO 03/026675 (2003-04-01), None
patent: WO 03/039523 (2003-05-01), None
patent: WO 03/053349 (2003-07-01), None
patent: WO 2004/002422 (2004-01-01), None
patent: WO 2004/002999 (2004-01-01), None
patent: WO 2004/003000 (2004-01-01), None
patent: WO 2004/037855 (2004-05-01), None
patent: WO 2004/046159 (2004-06-01), None
patent: WO 2004/046331 (2004-06-01), None
patent: WO 2005/010029 (2005-02-01), None
patent: WO 2005/028501 (2005-03-01), None
patent: WO 2005/073195 (2005-08-01), None
patent: WO 2005/073216 (2005-08-01), None
patent: WO 2006/021341 (2006-03-01), None
Klump et al. J Bio Chem. 281 (7) 2006 pp. 3793-3799.
Carroll et al. J Bio Chem. 273 (14) 2003 pp. 11979-11984.
Carroll, et al, J Biol Chem (2003), 278(14), p. 11979-11984.
Jin, et al, Arch Pharm Res, (1995), 18(5), p. 364-365.
Jeon, et al, Tetrahedron, (1996), 52(39), p. 12643-12650.
Waga, et al, Nucleosides & Nucleotides, (1996), 15(1-3), p. 287-304.
Kitano, et al, Tetrahedron, (1997), 53(39), p. 13315-13322.
Maag, et al, J Med Chem, (1992), 35, p. 1440-1451.
Kohgo, et al, Biosci Biotechnol Biochem, (1999), 63(6), p. 1146-1149.
Kohgo, et al, Nucleic Acid Symposium Series, (1999), 42, p. 127-128.
Kodama, et al, Antimicrob Ag Chemother, (2001), 45(5), p. 1539-1546.
Ohrui, et al, J Med Chem, (2000), 43, p. 4516-4625.
Wu, et al, Curr Drug Targ Inf Dis, (2003), 3(3), p. 207-219.
Yamaguchi, et al, Nucleosides & Nucleotides, (1997), 16(7-9), p. 1347-1350.
Sugimoto, et al, Biorg Med Chem Lett, (1999), 9, p. 385-388.
Yang, et al, Tetrahedron Lett, (1992), 33(1), p. 37-40.
Yang, et al, Tetrahedron Lett, (1992), 33(1), p. 41-44.
Borthwick, et al, J Med Chem, (1990), 33, p. 179-186.
Cicero, et al, Biorg Med Chem Lett, (1994), 4(7), p. 861-866.
Murakimi, et al, Antimicrob Ag Chemother, (2007), 51(2), p. 503-509.
Klump, et al, J Biol Chem, (2006), 281(7), p. 3793-3799.
Klump, et al, J Biol Chem, (2008), 283(4), p. 2167-2175.
Smith, et al, Biorg Med Chem Lett, (2007), 17, p. 2570-2576.
Johansson Nils-Gunnar
Kalyanov Genadiy
Martin Joseph Armstrong
Smith David Bernard
Winqvist Anna
Birch & Stewart Kolasch & Birch, LLP
McIntosh, III Traviss C
Medivir AB
LandOfFree
Antiviral nucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral nucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral nucleosides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4213377